Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface.
about
Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injuryElevated level of fibrinogen increases caveolae formation; role of matrix metalloproteinase-9.Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia.Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cellsAblation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitroCaveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment.Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with.Targeting nitric oxide for cancer therapy.Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability.Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21.Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury.Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery.
P2860
Q26995130-8AF2AA06-0390-4B00-A065-B6EFD13984B4Q33610999-D349BD1B-52CA-4B18-A632-69B366BE3210Q34153400-B8DFA47B-3E5C-4C79-B5B7-0D095EA410BEQ34269018-DB12F89F-018D-4140-8602-0BBCE720C4F2Q34422275-D01967B9-3916-47A8-8506-DE6C18024578Q35635108-356A3A73-B898-4481-9DFA-BCB22A098BA2Q36095644-14581D3C-65DB-468D-991C-CEA5ED636694Q36584877-B541AF05-B365-4D8D-930A-DF4571460844Q36709690-E274B183-6E8A-4A97-8E17-7381D605E4C3Q36802414-6FEB2A79-A54B-4FAB-A0BD-75E9210FE5DFQ42137731-33447906-3105-443C-934D-75C77F128CC4Q42675871-D2D86FEA-D6AD-46D8-B7EE-563C07B51BF6Q42844116-79C6EA7F-77A3-4EC4-9FAF-FB9131E2AEB4Q46897514-025BCC8A-163F-49A4-84F2-3179249DCE02Q54982616-1C03244E-F5E2-446F-AE1B-B5C38DAC758C
P2860
Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@ast
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@en
type
label
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@ast
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@en
prefLabel
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@ast
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@en
P2860
P1476
Nitric oxide modulates caveoli ...... ial cell/tumor cell interface.
@en
P2093
Linda M Birnby
Patricia G Phillips
P2860
P304
P356
10.1152/AJPLUNG.00262.2003
P577
2004-05-01T00:00:00Z